Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immunic, Inc. - Common Stock (NQ:IMUX)

0.7400 -0.0300 (-3.90%)
Streaming Delayed Price Updated: 2:54 PM EDT, Sep 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,772,800
Open 0.7728
Bid (Size) 0.7399 (16)
Ask (Size) 0.7400 (2)
Prev. Close 0.7700
Today's Range 0.7388 - 0.7865
52wk Range 0.5610 - 2.110
Shares Outstanding 26,249,439
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Immunic (IMUX) Q2 Loss Widens 25%
Via The Motley Fool
Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial
Via Stocktwits

Performance

YTD
-27.5%
-27.5%
1 Month
-24.6%
-24.6%
3 Month
-4.3%
-4.3%
6 Month
-35.7%
-35.7%
1 Year
-47.1%
-47.1%

More News

Read More
Immunic to Participate in Scientific and Industry Conferences in May
Via Stocktwits
Topics Economy
Immunic, Inc. Announces Proposed Public Offering
Via Stocktwits
Topics Regulatory Compliance
Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering
Via Stocktwits
Immunic to Participate in Investor, Scientific and Industry Conferences in June
Via Stocktwits
Topics Intellectual Property
Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering
Via Stocktwits
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS
Via Stocktwits
Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis
Via Stocktwits
Let's take a look at the stocks that are in motion in today's session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Wednesday's session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Wednesday's session: gap up and gap down stocks
Via Chartmill
These stocks that are showing activity before the opening bell on Wednesday.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Immunic Stock Draws Investor Attention On $5.1M Registered Direct Offering: Retail’s On Wait-And-Watch Mode
Via Stocktwits
Topics Intellectual Property Lawsuit
Immunic to Present at the November 21st Virtual Investor Summit Microcap Event
Via ACCESSWIRE
This Yelp Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Peek Behind the Curtain: 7 Penny Stocks With Heavy Insider Buying
Via InvestorPlace
Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day
Via TheNewswire.com
Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day
Via News Direct
Immunic chief medical officer discusses promising treatments to mark World IBD Day
Via News Direct
Immunic chief medical officer discusses promising treatments to mark World IBD Day
Via TheNewswire.com

Frequently Asked Questions

Is Immunic, Inc. - Common Stock publicly traded?
Yes, Immunic, Inc. - Common Stock is publicly traded.
What exchange does Immunic, Inc. - Common Stock trade on?
Immunic, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Immunic, Inc. - Common Stock?
The ticker symbol for Immunic, Inc. - Common Stock is IMUX on the Nasdaq Stock Market
What is the current price of Immunic, Inc. - Common Stock?
The current price of Immunic, Inc. - Common Stock is 0.7400
When was Immunic, Inc. - Common Stock last traded?
The last trade of Immunic, Inc. - Common Stock was at 09/05/25 02:54 PM ET
What is the market capitalization of Immunic, Inc. - Common Stock?
The market capitalization of Immunic, Inc. - Common Stock is 19.42M
How many shares of Immunic, Inc. - Common Stock are outstanding?
Immunic, Inc. - Common Stock has 19M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.